Lab21 provides expert Clinical Trial and Companion Diagnostics services in specialist diagnostis. Our services are used by pharmaceutical companies, CROs and biotechnology companies and range from assay development and clinical trial testing to assay manufacture,  regulatory approval, commercialisation and global distribution as products or services.

Lab21 is an experienced partner for clinical trials with proven record of accelerating drug discovery and market entry, and of building the shareholder value of its Clients. Our clinical trial support services are fully accredited and include a wide range or esoteric and routine testing services. Please click below for more information on our current assay technologies.

Targeted therapies that require biomarker testing by use of Companion Diagnostics is growing rapidly, requiring efficient combination of diagnostic testing with the provision of targeted pharmaceuticals. Lab21 is an experienced partner to aid market entry and success of such targeted therapies through its Companion Diagnostics solutions.

Lab21 has outstanding expertise in a wide range of assay technologies that are applicable in many different Therapy Areas including Oncology, Virology, Cardiology, Respiratory and Autoimmunity. With a wide range of disciplines encompassed by its staff, Lab21 has the experience to undertake a wide range of specialised or routine projects in any Therapy Area. Please see below for an overview and for examples of our experience in selected areas.

The Lab21 team is highly scientifically skilled with practical, solution oriented approach, and we have extensive experience of working in and with the pharmaceutical and CRO industry. Please click below for more information on how we work with you to deliver value to your organisation.